Analyst Consensus ?
ConsensusBuy34 ratings
Bullish1853.0%
Neutral1544.1%
Bearish12.9%
FN2 Earnings Intelligence
Church & Dwight Co., Inc. (CHD) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Barclays | Underweight | Underweight | Maintain | Jul 21, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 16, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 8, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jun 1, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | May 4, 2026 |
| TD Cowen | Hold | Hold | Maintain | Feb 20, 2026 |
| Rothschild & Co | Neutral | Sell | Upgrade | Feb 13, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Feb 2, 2026 |
| Jefferies | Buy | Buy | Maintain | Feb 2, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Feb 2, 2026 |
| Raymond James | Outperform | Market Perform | Upgrade | Jan 5, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Dec 10, 2025 |
| Argus Research | Buy | Buy | Maintain | Dec 4, 2025 |
| Oppenheimer | Outperform | Outperform | Maintain | Oct 21, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 8, 2025 |
| Truist Securities | Buy | Buy | Maintain | Jun 6, 2025 |
| Stifel | Hold | Hold | Maintain | Feb 3, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Feb 3, 2025 |
| HSBC | Hold | Hold | Maintain | May 3, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Mar 4, 2024 |
| Atlantic Equities | Neutral | Underweight | Upgrade | Feb 6, 2023 |
| Credit Suisse | Outperform | Neutral | Upgrade | Jan 17, 2023 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 15, 2020 |
| Bank of America | Buy | Buy | Maintain | Dec 19, 2019 |
| Stifel Nicolaus | Hold | Hold | Maintain | Aug 1, 2019 |
| Macquarie | Outperform | Outperform | Maintain | Mar 29, 2019 |
| BMO Capital | Market Perform | Market Perform | Maintain | Nov 2, 2018 |
| Societe Generale | Hold | Buy | Downgrade | Aug 7, 2018 |
| BTIG Research | Buy | Buy | Maintain | Nov 19, 2014 |
| KeyBanc | Hold | Hold | Maintain | Dec 16, 2013 |
| Credit Agricole | Outperform | Underperform | Upgrade | Feb 6, 2013 |
| Wellington Shields | Buy | Hold | Upgrade | Aug 24, 2012 |
| Gabelli & Co. | Hold | Buy | Downgrade | Feb 8, 2012 |
Upside is calculated against the persisted current price $97.68. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Goldman Sachs | Analyst unavailable | $111 | $95.63 | +13.6% | May 29, 2026 |
| UBS | Analyst unavailable | $100 | $93.5 | +2.4% | May 4, 2026 |
| RBC Capital | Analyst unavailable | $114 | $93.68 | +16.7% | May 4, 2026 |
| Deutsche Bank | Analyst unavailable | $109 | $93.61 | +11.6% | May 4, 2026 |
| Evercore ISI | Analyst unavailable | $105 | $93.99 | +7.5% | May 4, 2026 |
| RBC Capital | Dwight to | $112 | $96.16 | +14.7% | Apr 9, 2026 |
| Wells Fargo | Analyst unavailable | $110 | $101.45 | +12.6% | Feb 17, 2026 |
| Redburn Partners | Edward Lewis | $91 | $100 | -6.8% | Feb 13, 2026 |
| Morgan Stanley | Analyst unavailable | $105 | $97.66 | +7.5% | Feb 2, 2026 |
| Wells Fargo | Analyst unavailable | $105 | $96.25 | +7.5% | Feb 2, 2026 |
| UBS | Analyst unavailable | $92 | $89.1 | -5.8% | Jan 14, 2026 |
| Wells Fargo | Analyst unavailable | $92 | $82.69 | -5.8% | Jan 5, 2026 |
| Raymond James | Olivia Tong | $100 | $82.64 | +2.4% | Jan 5, 2026 |
| Jefferies | Kaumil Gajrawala | $102 | $84.55 | +4.4% | Dec 16, 2025 |
| Deutsche Bank | Steve Powers | $100 | $82.63 | +2.4% | Dec 10, 2025 |
| Argus Research | Analyst unavailable | $102 | $84.18 | +4.4% | Dec 4, 2025 |
| Barclays | Analyst unavailable | $82 | $86.28 | -16.1% | Nov 4, 2025 |
| Oppenheimer | Analyst unavailable | $100 | $88.08 | +2.4% | Oct 21, 2025 |
| Redburn Partners | Edward Lewis | $83 | $98.05 | -15.0% | Jul 14, 2025 |
| Truist Financial | Bill Chappell | $110 | $99.16 | +12.6% | Jun 6, 2025 |
| Barclays | Analyst unavailable | $97 | $108.39 | -0.7% | Mar 27, 2025 |
| Jefferies | Kaumil Gajrawala | $108 | $102.96 | +10.6% | Nov 4, 2024 |
| Piper Sandler | Korinne Wolfmeyer | $120 | $103.52 | +22.9% | Sep 23, 2024 |
| Stifel Nicolaus | Mark Astrachan | $105 | $100.08 | +7.5% | Aug 5, 2024 |
| BMO Capital | Phillip Jungwirth | $115 | $53.51 | +17.7% | Jun 3, 2024 |
| CFRA | Ana Garcia | $114 | $105.82 | +16.7% | May 3, 2024 |
| HSBC | Alejandro Zamacona | $110 | $105.88 | +12.6% | May 3, 2024 |
| Oppenheimer | Rupesh Parikh | $120 | $105.95 | +22.9% | Apr 23, 2024 |
| Argus Research | Taylor Conrad | $115 | $100.4 | +17.7% | Feb 23, 2024 |
| Deutsche Bank | Steve Powers | $110 | $91.96 | +12.6% | Nov 3, 2023 |
| Morgan Stanley | Dara Mohsenian | $114 | $91.48 | +16.7% | Oct 23, 2023 |
| Truist Financial | Bill Chappell | $105 | $94.44 | +7.5% | Aug 28, 2023 |
| Deutsche Bank | Analyst unavailable | $91 | $83.29 | -6.8% | Feb 6, 2023 |
| Morgan Stanley | Analyst unavailable | $92 | $82.9 | -5.8% | Feb 6, 2023 |
| J.P. Morgan | Analyst unavailable | $81 | $81.55 | -17.1% | Jan 13, 2023 |
| Wells Fargo | Analyst unavailable | $90 | $80.96 | -7.9% | Jan 3, 2023 |
| Argus Research | John Stasak | $78 | $72.59 | -20.1% | Nov 7, 2022 |
| Deutsche Bank | Steve Powers | $85 | $73.35 | -13.0% | Oct 5, 2022 |
| Jefferies | Analyst unavailable | $98 | $77.74 | +0.3% | Sep 14, 2022 |
| Deutsche Bank | Analyst unavailable | $90 | $80.66 | -7.9% | Sep 7, 2022 |
| Barclays | Analyst unavailable | $73 | $80.23 | -25.3% | Sep 7, 2022 |
| Goldman Sachs | Analyst unavailable | $93 | $86.87 | -4.8% | Aug 3, 2022 |
| Barclays | Analyst unavailable | $76 | $88.6 | -22.2% | Aug 2, 2022 |
| Truist Financial | Analyst unavailable | $100 | $88.29 | +2.4% | Aug 1, 2022 |
| Deutsche Bank | Analyst unavailable | $93 | $89.6 | -4.8% | Aug 1, 2022 |
| UBS | Analyst unavailable | $98 | $87.94 | +0.3% | Aug 1, 2022 |
| Morgan Stanley | Analyst unavailable | $82 | $87.86 | -16.1% | Aug 1, 2022 |
| J.P. Morgan | Analyst unavailable | $86 | $92.54 | -12.0% | Jul 21, 2022 |
| Wells Fargo | Chris Carey | $95 | $85.91 | -2.7% | Jun 21, 2022 |
| Barclays | Analyst unavailable | $77 | $88.75 | -21.2% | May 23, 2022 |
| Barclays | Analyst unavailable | $81 | $97.56 | -17.1% | May 2, 2022 |
| Barclays | Lauren Lieberman | $86 | $103.01 | -12.0% | Jan 13, 2022 |
| Wells Fargo | Christopher Carey | $100 | $102.26 | +2.4% | Jan 5, 2022 |
| Oppenheimer | Rupesh Parikh | $110 | $98.57 | +12.6% | Dec 20, 2021 |
| UBS | Peter Grom | $89 | $87.16 | -8.9% | Nov 1, 2021 |
| Morgan Stanley | Dara Mohsenian | $80 | $86.35 | -18.1% | Apr 19, 2021 |
Track every rating change on CHD the moment it posts. Free to start.
Start free